May 27, 2020
EC approves BMS’s Zeposia to treat patients with certain MS
Zeposia offers relapsing remitting multiple sclerosis (RRMS) patients with active disease in the European Union a new oral option to…
Pharmaceuticals, Biotechnology and Life Sciences
Category: North America
May 26, 2020
Moderna to Host Virtual Science Day on June 2, 2020
CAMBRIDGE, Mass.–(BUSINESS WIRE)–Moderna, Inc., (Nasdaq: MRNA) a clinical stage biotechnology company pioneering messenger RNA (mRNA) therapeutics and vaccines to create…
May 26, 2020
insitro Announces $143 Million Raised in Series B Financing
Proceeds will fund the expansion of insitro’s machine-learning-enabled drug discovery capabilities and the advancement of proprietary and partnered therapeutic programs…
May 26, 2020
Merck Announces Third-Quarter 2020 Dividend
KENILWORTH, N.J.–(BUSINESS WIRE)–$MRK #MRK–Merck (NYSE: MRK), known as MSD outside the United States and Canada, today announced that the Board…
May 26, 2020
PharmaCyte Biotech Announces Final Major Study for IND Submission Has Begun
LAGUNA HILLS, Calif.–(BUSINESS WIRE)–#INDstatus–PharmaCyte Biotech, Inc. (OTCQB: PMCB), a biotechnology company focused on developing cellular therapies for cancer and diabetes…
May 22, 2020
Tricida nets from the offering approximately $193M
Tricida estimates that the net proceeds from the offering will be approximately $193.0 million
May 22, 2020
U.S. FDA OKs Takeda’s Alunbrig for rare and serious lung cancer patients
Takeda’s Alunbrig long-Term results from the phase 3 ALTA 1L trial established Alunbrig as a superior first-line treatment compared to crizotinib for people with ALK+ metastatic NSCLC, including those with brain metastases.
May 22, 2020
Eagle Pharmaceuticals Announces Change to Virtual Format for 2020 Annual Meeting of Stockholders
WOODCLIFF LAKE, N.J.–(BUSINESS WIRE)–Eagle Pharmaceuticals, Inc. (Nasdaq: EGRX) (“Eagle”) announced today that, due to public health and safety concerns related…
May 22, 2020
AstraZeneca gets more than $1B investment making the COVID-19 vaccine
AstraZeneca has concluded the first agreements for at least 400 million doses and has secured total manufacturing capacity for one billion doses so far and will begin first deliveries in September 2020.
May 22, 2020
Colorado BioScience Association Congratulates New Class of Boettcher Investigators
$1.88 million in biomedical research grant funding for 2020 Class DENVER–(BUSINESS WIRE)–#cobioscience–The Boettcher Foundation has selected eight researchers to receive…